Author Correction: A new tau dephosphorylation-targeting chimera for the treatment of tauopathies

IF 6.9 1区医学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Acta Pharmacologica Sinica Pub Date : 2024-09-16 DOI:10.1038/s41401-024-01379-5

Jing-fen Su, Yue Xiao, Lin-yu Wei, Hui-yang Lei, Fei Sun, Wei-xia Wang, Shi-hong Li, Xiao-chuan Wang, Jie Zheng, Jian-zhi Wang

引用次数: 0

Abstract Image

查看原文本刊更多论文

作者更正：用于治疗陶陶病的新型陶陶去磷酸化靶向嵌合体

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Acta Pharmacologica Sinica 医学-化学综合

CiteScore

15.10

自引率

2.40%

发文量

4365

审稿时长

2 months

期刊介绍： APS (Acta Pharmacologica Sinica) welcomes submissions from diverse areas of pharmacology and the life sciences. While we encourage contributions across a broad spectrum, topics of particular interest include, but are not limited to: anticancer pharmacology, cardiovascular and pulmonary pharmacology, clinical pharmacology, drug discovery, gastrointestinal and hepatic pharmacology, genitourinary, renal, and endocrine pharmacology, immunopharmacology and inflammation, molecular and cellular pharmacology, neuropharmacology, pharmaceutics, and pharmacokinetics. Join us in sharing your research and insights in pharmacology and the life sciences.